Additionally, another exception occurred while executing the custom error page for the first exception. Chloroquine retinopathy, is a form of toxic retinopathy (damage of the retina) caused by the drugs chloroquine or hydroxychloroquine, which are sometimes used in the treatment of autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus. Plaquenil maculopathy fa Plaquenil and raynaud& 39 Chloroquine hcc Should i take hydroxychloroquine Chloroquine and hydroxychloroquine bind to melanin in the retinal pigment epithelium RPE and cause damage to the macular cones outside of the fovea. The drugs inhibit RPE lysosome activity, reduce phagocytosis of shed photoreceptor outer segments causing an accumulation of outer receptor segments. The risk of developing retinal toxicity has been found to be dependent on the daily HCQ dose and the duration of use. The risk of retinal toxicity is 1% for those who use HCQ for up to 5 years and 2% for those who use HCQ for 5–10 years, but it rises to almost 20% after 20 years of HCQ use. Hydroxychloroquine Retinal Toxicity A 57-year-old woman receiving long-term hydroxychloroquine treatment presented for ophthalmic evaluation. Achromatic perimetry revealed paracentral scotomas in e. The risk of toxicity is low for individuals without complicating conditions during the first 5 years of treatment using less than 6.5 mg/kg/day of hydroxychloroquine or 3 mg/kg/day of chloroquine, and/or cumulative doses of less than 1000 gram and 460 gram (total dose), respectively. This eye toxicity limits long-term use of the drugs. Retinal toxicity hydroxychloroquine Despite Plaquenil dosing recommendations, retinal toxicity., Retinal Toxicity in Patients Treated With Hydroxychloroquine. Plaquenil and stem cell injectionCombination of plaquenil and methotrexateHow quickly does plaquenil workWhat happens if you double doses of plaquenilChloroquine drug class Hydroxychloroquine, sold under the brand name Plaquenil Sanofi-Aventis, is an antimalarial drug that has gained widespread use in treating various autoimmune diseases, including systemic lupus erythematosus and rheumatoid arthritis. 1 By some estimates, more than 150,000 patients are on long-term therapy with this medication in America alone. 2 Retinal toxicity associated with HCQ use is. Multimodal Imaging in Plaquenil Toxicity. Hydroxychloroquine Retinal Toxicity NEJM. Retinal Toxicity Associated With Hydroxychloroquine and.. This article is from June 2011 and may contain outdated material. Download PDF. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. Rheumatologists use hydroxychloroquine sulfate Plaquenil, Concordia Pharmaceuticals to treat autoimmune diseases, namely discoid or systemic lupus erythematosus, rheumatoid arthritis, Sjögren syndrome, and malaria. When taken at high doses and for long durations, hydroxychloroquine has been known to cause parafoveal retinal toxicity. New information shows that hydroxychloroquine retinal toxicity occurs 7.5 percent of the time, which is not that rare. 3. In those patients who are affected, their daily dose and duration of use varied widely.